<DOC>
	<DOCNO>NCT01814189</DOCNO>
	<brief_summary>The purpose study show efficacy promethazine management patient moderate severe migraine</brief_summary>
	<brief_title>Efficacy Safety Oral Sumatriptan Plus Oral Promethazine Migraine Treatment</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Migraine without Aura</mesh_term>
	<mesh_term>Migraine Aura</mesh_term>
	<mesh_term>Sumatriptan</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<criteria>Patients age 18 65 year clinical history migraine without aura ( International Headache Society categories 1.1 1.2 ) least 1 year Subjects mean frequency 28 migraine attack per month . Complex form migraine , medication overuse headache , history chronic tensiontype headache , ophthalmoplegic , basilar hemiplegic migraine Uncontrolled hypertension ( diastolic blood pressure &gt; 95 mm Hg systolic blood pressure &gt; 160 mm Hg ) History clinical evidence cerebrovascular cardiovascular disorder Renal impairment dialysis dependence Serious illness ( physical psychiatric disorder ) Drugs alcohol abuse Pregnancy breastfeed Allergy hypersensitivity promethazine triptans Concurrent use ergotaminecontaining drug , monoamine oxidize inhibitor , antidepressant , lithium</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>